After US Study, Pfizer’s 20-Valent Pneumococcal Jab Aces European Infant Study
Pfizer Inc (NYSE:PFE) announced positive topline results from its European Phase 3 study in infants evaluating its 20-valent pneumococcal conjugate vaccine…
Europe Approves First Bispecific Antibody From Roche For Two Eye Disorders
The European Commission approved Roche Holding AG’s (OTC:RHHBY) Vabysmo (faricimab) for neovascular or ‘wet’ age-related macular degeneration (nAMD) and visual impairment…
European Authority Backs AbbVie’s Crohn’s Disease Candidate
The European Medicines Agency’s Committee for Medicinal Products for Human Use has adopted a positive opinion recommending approval of AbbVie Inc’s (NYSE:ABBV)…
Virios Therapeutics Shares Tank After Failing Fibromyalgia Study
Virios Therapeutics Inc’s (NASDAQ:VIRI) shares crashed after its FORTRESS Phase 2b trial of IMC-1 antiviral combination therapy for fibromyalgia failed…
Teva To Start Nationwide Settlement Of Opioid Lawsuits From Next Year: Report
Reuters reported that Teva Pharmaceutical Industries Ltd’s (NYSE:TEVA) CEO said the company will finalize the U.S. opioid settlement by the end…
Valneva Cuts Ties With Its COVID-19 Vaccine Manufacturing Partner In Germany
Valneva SE (NASDAQ:VALN) and IDT Biologika will terminate their collaboration following the delivery of inactivated COVID-19 bulk vaccine to Valneva and…
Recent Selloff Is A ‘Buying Opportunity’ For This NASH Stock, Says Analyst
Yesterday, Altimmune Inc (NASDAQ:ALT) announced results from a Phase 1b trial evaluating pemvidutide (ALT-801), a novel glucagonlike peptide-1 (GLP-1) and glucagon dual…
Top US Drugmakers Exploit US Patent System To Keep Generic Competition At Bay: Report
Citing the Initiative for Medicines, Access & Knowledge’s (I-MAK) report, Reuters said that several makers of top-selling drugs…
Goldman Sachs Comes Under Federal Probe For Its Consumer Unit: Report
Bloomberg reported that Goldman Sachs Group Inc’s (NYSE:GS) consumer banking unit, dubbed Marcus, is under Federal Reserve scrutiny, citing people familiar…
Germany Takes Russia’s Rosneft’s Subsidiary Under State Control
The German government says it is taking control of Russian oil giant Rosneft's (OTC: RNFTF) subsidiary in Germany, citing the need to ensure continued operations at three oil refineries and secure energy supplies which have been disrupted after Moscow invaded Ukraine.